Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Linda Dirven

Showing results (21-30 of 144) with videos related to

Pageof 15
Sort By:
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|June 5, 2025
Neurocognitive impairment and patient-proxy agreement on health-related quality of life evaluations in recurrent high-grade glioma patientsIvan Caramanna, Martin Klein, Martin van den Bent, et al.
Cancers|November 12, 2016
Advance Care Planning in Glioblastoma PatientsLara Fritz, Linda Dirven, Jaap C Reijneveld, et al.
Journal of Neuro-Oncology|February 21, 2021
MMSE is an independent prognostic factor for survival in primary central nervous system lymphomaMatthijs van der Meulen, Linda Dirven, Katerina Bakunina, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 15, 2022
Diagnostic accuracy of MRI techniques for treatment response evaluation in patients with brain metastasis: A systematic review and meta-analysisWouter H T Teunissen, Chris W Govaerts, Miranda C A Kramer, et al.
Journal of Neuro-Oncology|November 9, 2015
Seizure reduction is a prognostic marker in low-grade glioma patients treated with temozolomideJohan A F Koekkoek, Linda Dirven, Jan J Heimans, et al.
Neuro-Oncology Practice|June 9, 2025
Seizure outcomes in patients with brain metastases and epilepsy: a systematic review on the efficacy of antitumor treatment and antiseizure medicationJosien C C Scheepens, Pim B van der Meer, Linda Dirven, et al.
Rheumatology (Oxford, England)|February 9, 2013
A multi-biomarker score measures rheumatoid arthritis disease activity in the BeSt studyShintaro Hirata, Linda Dirven, Yijing Shen, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 25, 2014
Seizure reduction in a low-grade glioma: more than a beneficial side effect of temozolomideJohan A F Koekkoek, Linda Dirven, Jan J Heimans, et al.
Journal of Neuro-Oncology|January 3, 2020
Prediagnostic symptoms and signs of adult glioma: the patients' viewMarthe C M Peeters, Linda Dirven, Johan A F Koekkoek, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|August 5, 2025
Challenges in interpreting individual-level changes in health-related quality of life in patients with glioma using minimally important differences (MIDs) and a 4-point Likert scaleOgechukwu A Asogwa, Johan A F Koekkoek, Marthe C M Peeters, et al.
Pageof 15

Showing results (21-30 of 144) with videos related to

Sort By:
Pageof 15
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|June 5, 2025
Neurocognitive impairment and patient-proxy agreement on health-related quality of life evaluations in recurrent high-grade glioma patientsIvan Caramanna, Martin Klein, Martin van den Bent, et al.
Cancers|November 12, 2016
Advance Care Planning in Glioblastoma PatientsLara Fritz, Linda Dirven, Jaap C Reijneveld, et al.
Journal of Neuro-Oncology|February 21, 2021
MMSE is an independent prognostic factor for survival in primary central nervous system lymphomaMatthijs van der Meulen, Linda Dirven, Katerina Bakunina, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 15, 2022
Diagnostic accuracy of MRI techniques for treatment response evaluation in patients with brain metastasis: A systematic review and meta-analysisWouter H T Teunissen, Chris W Govaerts, Miranda C A Kramer, et al.
Journal of Neuro-Oncology|November 9, 2015
Seizure reduction is a prognostic marker in low-grade glioma patients treated with temozolomideJohan A F Koekkoek, Linda Dirven, Jan J Heimans, et al.
Neuro-Oncology Practice|June 9, 2025
Seizure outcomes in patients with brain metastases and epilepsy: a systematic review on the efficacy of antitumor treatment and antiseizure medicationJosien C C Scheepens, Pim B van der Meer, Linda Dirven, et al.
Rheumatology (Oxford, England)|February 9, 2013
A multi-biomarker score measures rheumatoid arthritis disease activity in the BeSt studyShintaro Hirata, Linda Dirven, Yijing Shen, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 25, 2014
Seizure reduction in a low-grade glioma: more than a beneficial side effect of temozolomideJohan A F Koekkoek, Linda Dirven, Jan J Heimans, et al.
Journal of Neuro-Oncology|January 3, 2020
Prediagnostic symptoms and signs of adult glioma: the patients' viewMarthe C M Peeters, Linda Dirven, Johan A F Koekkoek, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|August 5, 2025
Challenges in interpreting individual-level changes in health-related quality of life in patients with glioma using minimally important differences (MIDs) and a 4-point Likert scaleOgechukwu A Asogwa, Johan A F Koekkoek, Marthe C M Peeters, et al.
Pageof 15